John Mulligan
Signal active
Founder and CEO
Contact Information
Social
Primary Organization
Bonum Therapeutics
Founded
2021
Employees
11-50
Industry
Biotechnology, Life Science, Medical, Therapeutics
Bio
John Mulligan is the Founder and CEO at Bonum Therapeutics. He previously worked at Good Therapeutics. Additionally, John Mulligan has had 2 past jobs including Founder and CEO at Glycostasis.
Location
Seattle, Washington, United States, North America
Jobs history
2
Bonum Therapeutics
Founder and CEO
2022 - Current
Glycostasis
Founder and CEO
2012 - 2015
Educations
3
Massachusetts Institute of Technology
Biology
Stanford University
Biology
Stanford University
Profile Resume
John Mulligan is the Founder and CEO at Bonum Therapeutics, based in United States, North America. With a background in Biotechnology, John Mulligan has a rich history of leadership and innovation.John Mulligan studied unknown Biology at Massachusetts Institute of Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.